Engineering peptide-MHC/co-stimulator-based nanoparticle vaccines for the treatment of metastatic cancer

用于治疗转移性癌症的工程肽-MHC/共刺激剂纳米颗粒疫苗

• 批准号: 335866
• 负责人: Shao Kun
• 金额: $ 10.2万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-09-01 至 2017-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=335866&lang=en
• 关键词: Biomaterials; Bionanomedicines; Cancer Immunotherapy; Co-Stimulatory Molecules; Metastatic Cancer; Nanovaccines; Peptide-Major Histocompatibility Complexes

Cancer is the leading cause of death in the world. Although the last decade has witnessed significant advances in the treatment of cancer, most cancers remain incurable, making this disorder an ongoing huge health care challenge for governments worldwide.

癌症是世界上主要的死亡原因。尽管过去十年在癌症治疗方面取得了重大进展，但大多数癌症仍然无法治愈，使这种疾病成为世界各国政府面临的巨大医疗挑战。